Ultralife Corporation (ULBI) trades at $7.55, marking a decrease of 2.96% on the day. The share price remains well above its MA-20 ($6.47), MA-50 ($6.77), and MA-200 ($6.44), confirming a bullish setup across all major moving averages.
Highlights
- Ultralife trades well above key moving averages, confirming a bullish setup across short-, medium-, and long-term horizons.
- Momentum indicators show mixed signals with overbought conditions and weak trend strength, suggesting vulnerability to a short-term pause or pullback.
- Expected near-term trading range is $7.47 to $7.60, with upside favored if $7.60 is breached or deeper retracement likely if $7.47 breaks.
Diverging momentum signals dampen intraday advance after early gap
Momentum indicators show a mixed short-term outlook. The Moving Average Convergence Divergence (MACD) is neutral and the Average Directional Index (ADX) is weak, signaling only moderate trend strength. The Relative Strength Index (RSI) is in bullish territory at 67.63, but the Stochastic RSI and Commodity Channel Index (CCI) both indicate overbought conditions. The Bull/Bear Power (BBP) is strongly positive at 1.40, signaling buyers dominate intraday momentum, but this is within an overbought context. The Awesome Oscillator remains neutral and does not reinforce the uptrend. The stock is under pressure, slipping 2.96% on the day after opening with a small upside gap of about $0.07. Price is near the bottom of today’s range and intraday volatility stands at 0.64%. The overall tone is corrective after the open, with momentum indicators diverging and warning of a possible short-term pause or pullback.
Earlier, analysts noted that Ultralife's strong bullish momentum was supported by insider buying and positive technical positioning, suggesting ongoing upside potential. The current moderation in price and overbought signals introduce a more cautious near-term outlook, making a decisive move above $7.60 the key trigger for renewed upside.
Latest Ultralife News
- Forex
- Crypto